Hsbc Holdings PLC Lowers Stake in ICU Medical, Inc. (NASDAQ:ICUI)

Hsbc Holdings PLC decreased its holdings in ICU Medical, Inc. (NASDAQ:ICUI - Free Report) by 32.2% in the second quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 7,102 shares of the medical instruments supplier's stock after selling 3,371 shares during the quarter. Hsbc Holdings PLC's holdings in ICU Medical were worth $846,000 as of its most recent SEC filing.

Other institutional investors and hedge funds have also recently added to or reduced their stakes in the company. Scout Investments Inc. increased its stake in ICU Medical by 16.3% during the 1st quarter. Scout Investments Inc. now owns 51,819 shares of the medical instruments supplier's stock valued at $5,463,000 after purchasing an additional 7,272 shares in the last quarter. Wakefield Asset Management LLLP acquired a new stake in ICU Medical during the 1st quarter worth about $989,000. Vanguard Group Inc. grew its stake in ICU Medical by 14.8% during the 4th quarter. Vanguard Group Inc. now owns 2,440,729 shares of the medical instruments supplier's stock valued at $243,438,000 after purchasing an additional 315,103 shares during the last quarter. SG Americas Securities LLC increased its holdings in shares of ICU Medical by 441.7% in the second quarter. SG Americas Securities LLC now owns 5,818 shares of the medical instruments supplier's stock valued at $691,000 after purchasing an additional 4,744 shares during the period. Finally, Sei Investments Co. raised its stake in shares of ICU Medical by 52.1% in the first quarter. Sei Investments Co. now owns 28,586 shares of the medical instruments supplier's stock worth $3,068,000 after purchasing an additional 9,793 shares during the last quarter. 96.10% of the stock is currently owned by hedge funds and other institutional investors.

Wall Street Analysts Forecast Growth

ICUI has been the topic of a number of recent research reports. Raymond James upped their target price on ICU Medical from $158.00 to $190.00 and gave the company an "outperform" rating in a research report on Thursday, September 12th. StockNews.com raised shares of ICU Medical from a "hold" rating to a "buy" rating in a report on Thursday, September 12th. Needham & Company LLC reaffirmed a "hold" rating on shares of ICU Medical in a report on Thursday, August 8th. Finally, KeyCorp lifted their price objective on ICU Medical from $136.00 to $147.00 and gave the company an "overweight" rating in a research note on Thursday, August 8th. One analyst has rated the stock with a hold rating and four have issued a buy rating to the company. Based on data from MarketBeat.com, the stock presently has an average rating of "Moderate Buy" and an average price target of $149.00.

ICU Medical Stock Performance

Shares of NASDAQ ICUI opened at $174.47 on Monday. The company has a market capitalization of $4.25 billion, a PE ratio of -71.21 and a beta of 0.65. The company has a debt-to-equity ratio of 0.76, a quick ratio of 1.08 and a current ratio of 2.41. The company's fifty day moving average price is $154.77 and its 200 day moving average price is $124.17. ICU Medical, Inc. has a 1 year low of $78.28 and a 1 year high of $181.87.

ICU Medical (NASDAQ:ICUI - Get Free Report) last posted its earnings results on Wednesday, August 7th. The medical instruments supplier reported $1.56 EPS for the quarter, beating analysts' consensus estimates of $1.00 by $0.56. The firm had revenue of $596.50 million for the quarter, compared to analysts' expectations of $556.64 million. ICU Medical had a positive return on equity of 5.01% and a negative net margin of 3.07%. The company's quarterly revenue was up 8.6% on a year-over-year basis. During the same period last year, the firm earned $1.58 EPS. On average, research analysts predict that ICU Medical, Inc. will post 3.76 earnings per share for the current year.

Insider Activity at ICU Medical

In other ICU Medical news, CEO Vivek Jain sold 12,000 shares of the stock in a transaction on Friday, August 16th. The shares were sold at an average price of $156.04, for a total transaction of $1,872,480.00. Following the transaction, the chief executive officer now directly owns 104,593 shares of the company's stock, valued at $16,320,691.72. The transaction was disclosed in a legal filing with the SEC, which is accessible through the SEC website. In related news, VP Daniel Woolson sold 2,502 shares of the business's stock in a transaction that occurred on Friday, August 30th. The stock was sold at an average price of $163.22, for a total transaction of $408,376.44. Following the completion of the sale, the vice president now directly owns 13,107 shares in the company, valued at $2,139,324.54. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, CEO Vivek Jain sold 12,000 shares of the firm's stock in a transaction on Friday, August 16th. The shares were sold at an average price of $156.04, for a total value of $1,872,480.00. Following the completion of the transaction, the chief executive officer now owns 104,593 shares in the company, valued at approximately $16,320,691.72. The disclosure for this sale can be found here. In the last quarter, insiders have sold 28,552 shares of company stock valued at $4,537,802. 6.70% of the stock is owned by company insiders.

ICU Medical Profile

ICU Medical, Inc, together with its subsidiaries, develops, manufactures, and sells medical devices used in infusion therapy, vascular access, and vital care applications worldwide. Its infusion therapy products include needlefree products under the MicroClave, MicroClave Clear, and NanoClave brands; Neutron catheter patency devices; ChemoClave and ChemoLock closed system transfer devices, which are used to limit the escape of hazardous drugs or vapor concentrations, block the transfer of environmental contaminants into the system, and eliminates the risk of needlestick injury; Tego needle free connectors; Deltec GRIPPER non-coring needles for portal access; and ClearGuard, SwabCap, and SwabTip disinfection caps.